Molecular Partners AG ( MOLN) - Stock Earnings
MOLN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 24, 2026, midnight | — / — | — | — / — | — |
MOLN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -18.6 million USD | — USD |
| 2025Q4 | -19.9 million USD | — USD |
| 2026Q1 | -20.9 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
MOLN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -73.7 million USD | 8.4 million USD |
| 2024 | -59.8 million USD | 5.5 million USD |
| 2025 | -77.7 million USD | — USD |
| 2026 Est. | — | — |
MOLN
Price: $4
52 week price:
Earnings Per Share: -1.98 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Volume: 4126
Market Capitalization: 149.9 million